Eradication of Helicobacter pylori. Can methenamine, an antimicrobial designed to be effective at an acidic pH, meet this challenge?
Gespeichert in:
| Veröffentlicht in: | Medical hypotheses 2013-04, Vol.80 (4), p.507-507 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 507 |
|---|---|
| container_issue | 4 |
| container_start_page | 507 |
| container_title | Medical hypotheses |
| container_volume | 80 |
| creator | Paranjape, S.G Turankar, A.V Sontakke, S.D |
| description | |
| doi_str_mv | 10.1016/j.mehy.2012.12.021 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1316056887</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0306987713000029</els_id><sourcerecordid>1316056887</sourcerecordid><originalsourceid>FETCH-LOGICAL-c411t-40c0da561d2da87cc1f2a10cb7879e8c391a2b0fed90300ab3716972e2f72c7c3</originalsourceid><addsrcrecordid>eNp9kU-LFDEQxYMo7rj6BTxIjh62x_yZ6XSDuMiwOsKCB_Uc0pXqnYzpZEwyC3P3g5t2Vg8ehIIi8N4L71eEvORsyRlv3-yXE-5OS8G4WNZhgj8iC76WohFKqcdkwSRrm75T6oI8y3nPGOtXsntKLoSUar1i_YL8vEnGOjDFxUDjSLfoHcTBQMFEDycfk1vSjQl0wrLDYCYX8IrWtwnFTQ5SHJzx1GJ2dwEtLZEOSHEcEYq7R2rKbzG4-gk9bK9qDhZadi5T2BnvMdzh9XPyZDQ-44uHfUm-fbj5utk2t58_ftq8v21gxXlpVgyYNeuWW2FNpwD4KAxnMKhO9diB7LkRAxvR9rU5M4NUvO2VQDEqAQrkJXl9zj2k-OOIuejJZUDvTcB4zJpL3rJ123WqSsVZWhvmnHDUh-Qmk06aMz3T13s909czfV2n0q-mVw_5x2FC-9fyB3cVvD0LsLa8d5h0BocB0LpUgWkb3f_z3_1jB-9CvZ7_jifM-3hMofLTXOdq0F_m-8_n55UGY6KXvwCYGqt_</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1316056887</pqid></control><display><type>article</type><title>Eradication of Helicobacter pylori. Can methenamine, an antimicrobial designed to be effective at an acidic pH, meet this challenge?</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Paranjape, S.G ; Turankar, A.V ; Sontakke, S.D</creator><creatorcontrib>Paranjape, S.G ; Turankar, A.V ; Sontakke, S.D</creatorcontrib><identifier>ISSN: 0306-9877</identifier><identifier>EISSN: 1532-2777</identifier><identifier>DOI: 10.1016/j.mehy.2012.12.021</identifier><identifier>PMID: 23375409</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Anti-Infective Agents - chemistry ; Anti-Infective Agents - therapeutic use ; Helicobacter Infections - complications ; Helicobacter Infections - drug therapy ; Helicobacter Infections - microbiology ; Helicobacter pylori - drug effects ; Humans ; Hydrogen-Ion Concentration ; Internal Medicine ; Methenamine - administration & dosage ; Methenamine - chemistry ; Peptic Ulcer - drug therapy ; Peptic Ulcer - etiology ; Peptic Ulcer - microbiology</subject><ispartof>Medical hypotheses, 2013-04, Vol.80 (4), p.507-507</ispartof><rights>Elsevier Ltd</rights><rights>2013 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c411t-40c0da561d2da87cc1f2a10cb7879e8c391a2b0fed90300ab3716972e2f72c7c3</citedby><cites>FETCH-LOGICAL-c411t-40c0da561d2da87cc1f2a10cb7879e8c391a2b0fed90300ab3716972e2f72c7c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.mehy.2012.12.021$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23375409$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Paranjape, S.G</creatorcontrib><creatorcontrib>Turankar, A.V</creatorcontrib><creatorcontrib>Sontakke, S.D</creatorcontrib><title>Eradication of Helicobacter pylori. Can methenamine, an antimicrobial designed to be effective at an acidic pH, meet this challenge?</title><title>Medical hypotheses</title><addtitle>Med Hypotheses</addtitle><subject>Anti-Infective Agents - chemistry</subject><subject>Anti-Infective Agents - therapeutic use</subject><subject>Helicobacter Infections - complications</subject><subject>Helicobacter Infections - drug therapy</subject><subject>Helicobacter Infections - microbiology</subject><subject>Helicobacter pylori - drug effects</subject><subject>Humans</subject><subject>Hydrogen-Ion Concentration</subject><subject>Internal Medicine</subject><subject>Methenamine - administration & dosage</subject><subject>Methenamine - chemistry</subject><subject>Peptic Ulcer - drug therapy</subject><subject>Peptic Ulcer - etiology</subject><subject>Peptic Ulcer - microbiology</subject><issn>0306-9877</issn><issn>1532-2777</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU-LFDEQxYMo7rj6BTxIjh62x_yZ6XSDuMiwOsKCB_Uc0pXqnYzpZEwyC3P3g5t2Vg8ehIIi8N4L71eEvORsyRlv3-yXE-5OS8G4WNZhgj8iC76WohFKqcdkwSRrm75T6oI8y3nPGOtXsntKLoSUar1i_YL8vEnGOjDFxUDjSLfoHcTBQMFEDycfk1vSjQl0wrLDYCYX8IrWtwnFTQ5SHJzx1GJ2dwEtLZEOSHEcEYq7R2rKbzG4-gk9bK9qDhZadi5T2BnvMdzh9XPyZDQ-44uHfUm-fbj5utk2t58_ftq8v21gxXlpVgyYNeuWW2FNpwD4KAxnMKhO9diB7LkRAxvR9rU5M4NUvO2VQDEqAQrkJXl9zj2k-OOIuejJZUDvTcB4zJpL3rJ123WqSsVZWhvmnHDUh-Qmk06aMz3T13s909czfV2n0q-mVw_5x2FC-9fyB3cVvD0LsLa8d5h0BocB0LpUgWkb3f_z3_1jB-9CvZ7_jifM-3hMofLTXOdq0F_m-8_n55UGY6KXvwCYGqt_</recordid><startdate>20130401</startdate><enddate>20130401</enddate><creator>Paranjape, S.G</creator><creator>Turankar, A.V</creator><creator>Sontakke, S.D</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20130401</creationdate><title>Eradication of Helicobacter pylori. Can methenamine, an antimicrobial designed to be effective at an acidic pH, meet this challenge?</title><author>Paranjape, S.G ; Turankar, A.V ; Sontakke, S.D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c411t-40c0da561d2da87cc1f2a10cb7879e8c391a2b0fed90300ab3716972e2f72c7c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Anti-Infective Agents - chemistry</topic><topic>Anti-Infective Agents - therapeutic use</topic><topic>Helicobacter Infections - complications</topic><topic>Helicobacter Infections - drug therapy</topic><topic>Helicobacter Infections - microbiology</topic><topic>Helicobacter pylori - drug effects</topic><topic>Humans</topic><topic>Hydrogen-Ion Concentration</topic><topic>Internal Medicine</topic><topic>Methenamine - administration & dosage</topic><topic>Methenamine - chemistry</topic><topic>Peptic Ulcer - drug therapy</topic><topic>Peptic Ulcer - etiology</topic><topic>Peptic Ulcer - microbiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Paranjape, S.G</creatorcontrib><creatorcontrib>Turankar, A.V</creatorcontrib><creatorcontrib>Sontakke, S.D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Medical hypotheses</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Paranjape, S.G</au><au>Turankar, A.V</au><au>Sontakke, S.D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Eradication of Helicobacter pylori. Can methenamine, an antimicrobial designed to be effective at an acidic pH, meet this challenge?</atitle><jtitle>Medical hypotheses</jtitle><addtitle>Med Hypotheses</addtitle><date>2013-04-01</date><risdate>2013</risdate><volume>80</volume><issue>4</issue><spage>507</spage><epage>507</epage><pages>507-507</pages><issn>0306-9877</issn><eissn>1532-2777</eissn><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>23375409</pmid><doi>10.1016/j.mehy.2012.12.021</doi><tpages>1</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0306-9877 |
| ispartof | Medical hypotheses, 2013-04, Vol.80 (4), p.507-507 |
| issn | 0306-9877 1532-2777 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1316056887 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Anti-Infective Agents - chemistry Anti-Infective Agents - therapeutic use Helicobacter Infections - complications Helicobacter Infections - drug therapy Helicobacter Infections - microbiology Helicobacter pylori - drug effects Humans Hydrogen-Ion Concentration Internal Medicine Methenamine - administration & dosage Methenamine - chemistry Peptic Ulcer - drug therapy Peptic Ulcer - etiology Peptic Ulcer - microbiology |
| title | Eradication of Helicobacter pylori. Can methenamine, an antimicrobial designed to be effective at an acidic pH, meet this challenge? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T16%3A31%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Eradication%20of%20Helicobacter%20pylori.%20Can%20methenamine,%20an%20antimicrobial%20designed%20to%20be%20effective%20at%20an%20acidic%20pH,%20meet%20this%20challenge?&rft.jtitle=Medical%20hypotheses&rft.au=Paranjape,%20S.G&rft.date=2013-04-01&rft.volume=80&rft.issue=4&rft.spage=507&rft.epage=507&rft.pages=507-507&rft.issn=0306-9877&rft.eissn=1532-2777&rft_id=info:doi/10.1016/j.mehy.2012.12.021&rft_dat=%3Cproquest_cross%3E1316056887%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1316056887&rft_id=info:pmid/23375409&rft_els_id=S0306987713000029&rfr_iscdi=true |